<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7117787\results\search\disease\results.xml">
  <result pre="our narrative review appraised epidemiological and clinical aspects of the" exact="disease" post="including genetic diversity of coronavirus genus, mode of transmission,"/>
  <result pre="preventing its spread in some communities. Key Words COVID-19 severe" exact="acute" post="respiratory syndrome coronavirus 2 epidemiology public health communicable diseases"/>
  <result pre="its spread in some communities. Key Words COVID-19 severe acute" exact="respiratory" post="syndrome coronavirus 2 epidemiology public health communicable diseases emerging"/>
  <result pre="spread in some communities. Key Words COVID-19 severe acute respiratory" exact="syndrome" post="coronavirus 2 epidemiology public health communicable diseases emerging Introduction"/>
  <result pre="COVID-19 severe acute respiratory syndrome coronavirus 2 epidemiology public health" exact="communicable diseases" post="emerging Introduction Over the past few decades, a large"/>
  <result pre="even faster than the previous pandemics (3). Recent epidemics of" exact="viral" post="respiratory diseases in the world have started from China"/>
  <result pre="faster than the previous pandemics (3). Recent epidemics of viral" exact="respiratory" post="diseases in the world have started from China (except"/>
  <result pre="web-based service for quick alarming in case of an emerging" exact="disease" post="with unknown origin through common surveillance system. In the"/>
  <result pre="consequences of this action to prevent the spread of the" exact="disease" post="to other parts of the world. Although, China has"/>
  <result pre="MERS, and it would probably take longer to halve the" exact="disease" post="cases; meaning that control measures would have to be"/>
  <result pre="review different epidemiological and clinical aspects of the new emerging" exact="disease" post="along with specific measures by countries in the community"/>
  <result pre="Transmission and Incubation period Human to human transmission via either" exact="respiratory" post="droplets or close contacts was initially proposed as the"/>
  <result pre="Organization (WHO) report, 2019-nCoV is a unique virus that causes" exact="respiratory" post="disease, which spreads via oral and nasal droplets. Moreover,"/>
  <result pre="in the air in the form of aerosols and cause" exact="infection" post="in healthy people (9). Evidence of a study in"/>
  <result pre="disease, which decreased dramatically over time (10). There is a" exact="limited" post="number of evidence on oral-fecal transmissibility of the pathogen."/>
  <result pre="to 10% of confirmed patients with gastrointestinal symptoms such as" exact="diarrhea" post="(11,12), so fecal-oral transmission should be taken into account"/>
  <result pre="probable route through case investigation. Incubation period (the time from" exact="infection" post="to the onset of symptoms) for the new pathogen"/>
  <result pre="a population that everyone is supposed to be susceptible. For" exact="viral" post="pathogens in MERS and SARS epidemics, the index was"/>
  <result pre="of a family, aged 10-66 years were infected within a" exact="short" post="period after one member returned from Wuhan (8). As"/>
  <result pre="is the capability of the pathogen to establish and induce" exact="infection" post="with different clinical manifestations in human. According to WHO"/>
  <result pre="cases in China and recovery and mortality rates of the" exact="disease" post="among severe cases in Guangdong were 26.4 % and"/>
  <result pre="time interval between onset and developing severe symptoms such as" exact="hypoxia" post="was one week (22). In case studies that were"/>
  <result pre="infected with COVID-19 in China indicated mild symptoms of the" exact="disease" post="in this age group with no need for further"/>
  <result pre="for further intensive care (25). According to WHO report, COVID-19" exact="disease" post="among children seems to be rare with mild symptoms,"/>
  <result pre="seems to be rare with mild symptoms, about 2.4% of" exact="total" post="cases were reported in children and adolescents (aged under"/>
  <result pre="aged over 60 years and those with a background of" exact="chronic" post="diseases were at higher risk of developing severe disease"/>
  <result pre="of chronic diseases were at higher risk of developing severe" exact="disease" post="and death (22). Even though age is an important"/>
  <result pre="having a history of underlying diseases and/or co-infection with other" exact="infections" post="like Influenza virus and Klebsiella may accelerate the progress"/>
  <result pre="progress of symptoms and lead to poor prognosis of the" exact="disease" post="(26). However, findings from a study in Singapore shows"/>
  <result pre="with no history of underlying diseases may also develop severe" exact="disease" post="and need for intensive care (4). Virulence The virulence"/>
  <result pre="need for intensive care (4). Virulence The virulence of a" exact="disease" post="is usually measured on the basis of indicators such"/>
  <result pre="two epidemics (SARS and MERS), the case fatality rate was" exact="lower" post="and approximately 2% in COVID-19, and only less than"/>
  <result pre="MERS (N=1871) (29). There is a poor prognosis for the" exact="disease" post="in middle and older aged patients (28). In a"/>
  <result pre="of these studies has been certified to begin Phase-2 (33,34)." exact="Absence of" post="clinical symptoms, respiratory lesions in CT scan and two"/>
  <result pre="been certified to begin Phase-2 (33,34). Absence of clinical symptoms," exact="respiratory" post="lesions in CT scan and two negative RT-PCR tests"/>
  <result pre="reported several cases of COVID-19 with clinical manifestations of the" exact="disease" post="along with a positive test after discharging from hospital"/>
  <result pre="effective vaccine. Diagnosis Pathogen of COVID-19 has been detected in" exact="upper" post="and lower respiratory tracts in initial assessments. Moreover, viral"/>
  <result pre="Diagnosis Pathogen of COVID-19 has been detected in upper and" exact="lower" post="respiratory tracts in initial assessments. Moreover, viral RNA has"/>
  <result pre="Pathogen of COVID-19 has been detected in upper and lower" exact="respiratory" post="tracts in initial assessments. Moreover, viral RNA has been"/>
  <result pre="in upper and lower respiratory tracts in initial assessments. Moreover," exact="viral" post="RNA has been detected in fecal and blood samples"/>
  <result pre="is compared to the gold standard. This comparison resulted in" exact="lower" post="values of diagnostic accuracy for the new test. On"/>
  <result pre="is believed to be a core intervention in controlling the" exact="disease" post="(45). Surveillance system data provides reliable information for epidemiologists"/>
  <result pre="is examination of all suspected cases with symptoms of the" exact="disease" post="(mostly fever) and all people with a travel history"/>
  <result pre="travelers who are arriving from regions with high burden of" exact="disease" post="via indirect flights, which could be a source of"/>
  <result pre="disease via indirect flights, which could be a source of" exact="infection" post="in COVID-19-free countries (46). In a communicable disease outbreak,"/>
  <result pre="a source of infection in COVID-19-free countries (46). In a" exact="communicable disease" post="outbreak, essential data are usually collected in parallel from"/>
  <result pre="source of infection in COVID-19-free countries (46). In a communicable" exact="disease" post="outbreak, essential data are usually collected in parallel from"/>
  <result pre="increase in the number of cases and deaths due to" exact="pneumonia" post="may raise an alarm in COVID-19 free areas. A"/>
  <result pre="the quality of case detection, diagnosis and management. Detection of" exact="primary" post="confirmed cases with poor prognosis in early phase of"/>
  <result pre="surveillance systems and low performance of control activities against the" exact="disease" post="in community level. In this case, it should be"/>
  <result pre="contacts have been started in medical institutions. The Department of" exact="Disease" post="Control in Thailand scaled up the Emergency Operations Center"/>
  <result pre="Health requested local health governments to be aware of the" exact="respiratory" post="illnesses in Wuhan using the existing surveillance system for"/>
  <result pre="illnesses in Wuhan using the existing surveillance system for serious" exact="infectious" post="illnesses with unknown etiology. It has strengthened surveillance for"/>
  <result pre="with unknown etiology. It has strengthened surveillance for undiagnosed severe" exact="acute" post="respiratory illnesses. Quarantine and screening measures have been intensified"/>
  <result pre="unknown etiology. It has strengthened surveillance for undiagnosed severe acute" exact="respiratory" post="illnesses. Quarantine and screening measures have been intensified for"/>
  <result pre="Wuhan at the points of entry. Furthermore, National Institute of" exact="Infectious" post="Disease (NIID) established an in-house PCR assay for COVID-19."/>
  <result pre="at the points of entry. Furthermore, National Institute of Infectious" exact="Disease" post="(NIID) established an in-house PCR assay for COVID-19. Contact"/>
  <result pre="2 of the 4-level national crisis management system). Surveillance of" exact="pneumonia" post="cases has been strengthened in health facilities nationwide and"/>
  <result pre="Wuhan at the points of entry. The US centers for" exact="disease" post="control and prevention (CDC) activated its Emergency Response System"/>
  <result pre="on clinical manifestations is complicated and initial symptoms of the" exact="disease" post="are usually nonspecific. A large number of patients present"/>
  <result pre="that require further interventions in the early phase of the" exact="disease" post="(10). No approved drug regimen has been introduced to"/>
  <result pre="cases so far, antiviral treatments are used to alleviate the" exact="disease" post="symptoms. Studies on Remedesevir, as an antiviral agent, revealed"/>
  <result pre="malaria, with apparent effectiveness and acceptable safety against COVID-19 associated" exact="pneumonia" post="(48,49). Evaluating the efficacy of anti-influenza drugs such as"/>
  <result pre="methods; however, its effectiveness has not been proven in other" exact="viral" post="respiratory diseases and influenza, yet (50,51). Steroids and methylprednisolone"/>
  <result pre="however, its effectiveness has not been proven in other viral" exact="respiratory" post="diseases and influenza, yet (50,51). Steroids and methylprednisolone seem"/>
  <result pre="not recommend its use for COVID-19, except for patients with" exact="acute" post="respiratory distress syndrome (ARDS) (52,53). The effectiveness of other"/>
  <result pre="recommend its use for COVID-19, except for patients with acute" exact="respiratory" post="distress syndrome (ARDS) (52,53). The effectiveness of other medicines"/>
  <result pre="use for COVID-19, except for patients with acute respiratory distress" exact="syndrome" post="(ARDS) (52,53). The effectiveness of other medicines and regimens"/>
  <result pre="The effectiveness of other medicines and regimens such as Chloroquine," exact="Vitamin C," post="and Chinese medicine, as well as Lopinavir/Ritonavir combination therapy"/>
  <result pre="researchers and healthcare providers should concentrate on alleviation of the" exact="disease" post="among subgroups of patients and in different phases of"/>
  <result pre="among subgroups of patients and in different phases of the" exact="disease" post="(54). In addition, since the emerging virus has become"/>
  <result pre="measure at the community level. Through their experiences in previous" exact="communicable disease" post="epidemics, US public health authorities found that enhanced screening"/>
  <result pre="at the community level. Through their experiences in previous communicable" exact="disease" post="epidemics, US public health authorities found that enhanced screening"/>
  <result pre="consequence of population movements and large scale spread of the" exact="disease" post="all over the world (46,58). Even though children are"/>
  <result pre="nurses were voluntarily deployed to Wuhan, China (60). According to" exact="primary" post="reports from China and Singapre, working with protective equipment"/>
  <result pre="they are under tremendous stress due to probability of being" exact="infection" post="and transmitting the disease to their families through close"/>
  <result pre="stress due to probability of being infection and transmitting the" exact="disease" post="to their families through close contact (57). The high"/>
  <result pre="families through close contact (57). The high rates of hospital" exact="infection" post="in the recent pandemic emphasizes the importance of regular"/>
  <result pre="for the medical community, revealing weaknesses in management of emerging" exact="viral" post="diseases and reminding us that communicable diseases must never"/>
  <result pre="in management of emerging viral diseases and reminding us that" exact="communicable diseases" post="must never be underestimated or dealt with using insufficient"/>
  <result pre="3951022456574 2ZhangLShenFMChenFLinZOrigin and evolution of the 2019 novel coronavirus Clinical" exact="infectious diseases" post=": an official publication of the Infectious Diseases Society"/>
  <result pre="coronavirus Clinical infectious diseases : an official publication of the" exact="Infectious" post="Diseases Society of America2020 3PerlmanSAnother Decade, Another Coronavirus New"/>
  <result pre="Clinical infectious diseases : an official publication of the Infectious" exact="Diseases" post="Society of America2020 3PerlmanSAnother Decade, Another Coronavirus New England"/>
  <result pre="web-based dashboard to track COVID-19 in real time The Lancet" exact="Infectious" post="diseases2020 6KickbuschILeungGResponse to the emerging novel coronavirus outbreak BMJ"/>
  <result pre="development: focus on diagnostics BMJ global health2019 4Suppl 2e001105 8ChanJFYuanSKokKHToKKChuHYangJXingFLiuJYipCCPoonRWTsoiHWA" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
  <result pre="diagnostics BMJ global health2019 4Suppl 2e001105 8ChanJFYuanSKokKHToKKChuHYangJXingFLiuJYipCCPoonRWTsoiHWA familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
  <result pre="Issues That Require Attention and Action Jama2020 11GaoQYChenYXFangJY2019 novel coronavirus" exact="infection" post="and gastrointestinal tract Journal of digestive diseases2020 Feb 25"/>
  <result pre="al.Presumed Asymptomatic Carrier Transmission of COVID-19 Jama2020 2 21 14Coronavirus" exact="disease" post="2019 (COVID-19) Situation Report â€&quot; 302020Access Mar, 2020Available at"/>
  <result pre="at : https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200219-sitrep-30-covid-19.pdf?sfvrsn=3346b04f_2 15BackerJAKlinkenbergDWallingaJIncubation period of 2019 novel coronavirus (2019-nCoV)" exact="infections" post="among travellers from Wuhan, China, 20-28 January 2020 Euro"/>
  <result pre="17LiQGuanXWuPWangXZhouLTongYet al.Early Transmission Dynamics in Wuhan, China, of Novel Coronavirusâ€&quot;Infected" exact="Pneumonia" post="New England Journal of Medicine202038213119920731995857 18SwerdlowDLFinelliLPreparation for Possible Sustained"/>
  <result pre="coronavirus Journal of travel medicine2020 Mar 13272PubMed PMID: 32052846. Pubmed" exact="Central" post="PMCID: PMC7074654. Epub 2020/02/14. eng 22Report of the WHO-China"/>
  <result pre="Central PMCID: PMC7074654. Epub 2020/02/14. eng 22Report of the WHO-China" exact="Joint" post="Mission on Coronavirus Disease 2019 (COVID-19)2020 Access Mar, 2020Available"/>
  <result pre="2020/02/14. eng 22Report of the WHO-China Joint Mission on Coronavirus" exact="Disease" post="2019 (COVID-19)2020 Access Mar, 2020Available at: https://www.who.int/docs/default-source/coronaviruse/who-china-jointmission-on-covid-19-final-report.pdf 23JungS-mAkhmetzhanovARHayashiKLintonNMYangYYuanBet al.Real-Time"/>
  <result pre="severity of 2019-novel coronavirus (nCoV)2020 LondonImperial College London 25WeiMYuanJLiuYFuTYuXZhangZ-JNovel Coronavirus" exact="Infection" post="in Hospitalized Infants Under 1 Year of Age in"/>
  <result pre="NgJulianA HiscoxCoronaviruses in animals and humans BMJ2020368m63432075782 27collab: Novel Coronavirus" exact="Pneumonia" post="Emergency Response Epidemiology Team[The epidemiological characteristics of an outbreak"/>
  <result pre="Liu Xing Bing Xue Za Zhi20204121455132064853 28TianSHuNLouJChenKKangXXiangZet al.Characteristics of COVID-19" exact="infection" post="in Beijing The Journal of infection2020 804401632112886 29MahaseECoronavirus: covid-19"/>
  <result pre="has killed more people than SARS and MERS combined, despite" exact="lower" post="case fatality rate BMJ2020368m64132071063 30NovelCPEREThe epidemiological characteristics of an"/>
  <result pre="studies Viruses2020123254 33ModjarradKRobertsCCMillsKTCastellanoARPaolinoKMuthumaniKet al.Safety and immunogenicity of an anti-Middle East" exact="respiratory" post="syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm,"/>
  <result pre="Viruses2020123254 33ModjarradKRobertsCCMillsKTCastellanoARPaolinoKMuthumaniKet al.Safety and immunogenicity of an anti-Middle East respiratory" exact="syndrome" post="coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation"/>
  <result pre="vaccine: a phase 1, open-label, single-arm, dose-escalation trial The Lancet" exact="Infectious" post="Diseases201919910132231351922 34YongCYOngHKYeapSKHoKLTanWSRecent Advances in the Vaccine Development Against Middle"/>
  <result pre="Diseases201919910132231351922 34YongCYOngHKYeapSKHoKLTanWSRecent Advances in the Vaccine Development Against Middle East" exact="Respiratory" post="Syndrome-Coronavirus Frontiers in microbiology201910178131428074 35LanLXuDYeGXiaCWangSLiYet al.Positive RT-PCR Test Results"/>
  <result pre="From COVID-19 Jama2020 Feb 27 36LingYXuSBLinYXTianDZhuZQDaiFHet al.Persistence and clearance of" exact="viral" post="RNA in 2019 novel coronavirus disease rehabilitation patients Chinese"/>
  <result pre="al.Persistence and clearance of viral RNA in 2019 novel coronavirus" exact="disease" post="rehabilitation patients Chinese medical journal2020 Feb 28 37ZhouLLiuKLiuHG[Cause analysis"/>
  <result pre="37ZhouLLiuKLiuHG[Cause analysis and treatment strategies of &quot;recurrence&quot; with novel coronavirus" exact="pneumonia" post="(covid-19) patients after discharge from hospital] Zhonghua jie he"/>
  <result pre="= Zhonghua jiehe he huxi zazhi = Chinese journal of" exact="tuberculosis" post="and respiratory diseases2020430E02832118391 38LiZYiYLuoXXiongNLiuYLiSet al.Development and Clinical Application of"/>
  <result pre="jiehe he huxi zazhi = Chinese journal of tuberculosis and" exact="respiratory" post="diseases2020430E02832118391 38LiZYiYLuoXXiongNLiuYLiSet al.Development and Clinical Application of A Rapid"/>
  <result pre="diseases2020430E02832118391 38LiZYiYLuoXXiongNLiuYLiSet al.Development and Clinical Application of A Rapid IgM-IgG" exact="Combined" post="Antibody Test for SARS-CoV-2 Infection Diagnosis Journal of medical"/>
  <result pre="38LiZYiYLuoXXiongNLiuYLiSet al.Development and Clinical Application of A Rapid IgM-IgG Combined" exact="Antibody" post="Test for SARS-CoV-2 Infection Diagnosis Journal of medical virology2020"/>
  <result pre="Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2" exact="Infection" post="Diagnosis Journal of medical virology2020 Feb 27 39TONESCOVID-19 Hospital"/>
  <result pre="Diagnosis Journal of medical virology2020 Feb 27 39TONESCOVID-19 Hospital Adds" exact="Antibody" post="Tests as Discharge Requirement 2020, March 5[Available from: http://www.sixthtone.com/news/1005274/covid-19-hospital-addsantibody-tests-as-discharge-requirement"/>
  <result pre="41AiTYangZHouHZhanCChenCLvWet al.RadiologyCorrelation of Chest CT and RTPCR Testing in Coronavirus" exact="Disease" post="2019 (COVID-19) in China: A Report of 1014 Cases2020200642"/>
  <result pre="1014 Cases2020200642 42LeeflangMMRutjesAWReitsmaJBHooftLBossuytPMVariation of a testâ€™s sensitivity and specificity with" exact="disease" post="prevalence Cmaj201318511E537E4423798453 43LakesKDRestricted sample variance reduces generalizability Psychological assessment201325264323205627"/>
  <result pre="specificity with disease prevalence Cmaj201318511E537E4423798453 43LakesKDRestricted sample variance reduces generalizability" exact="Psychological" post="assessment201325264323205627 44ChosewoodLCWilsonDEBiosafety in microbiological and biomedical laboratories. US: Department"/>
  <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studies Bioscience trends2020 14172332074550 49WangMCaoRZhangLYangXLiuJXuMet al.Remdesivir and"/>
  <result pre="monoclonal antibodies for the treatment of influenza Current opinion in" exact="infectious" post="diseases20183165273430299360 51AlansariKToaimahFHAlmatarDHElTatawy LADavidsonBLQusadMIMMonoclonal antibody treatment of RSV bronchiolitis in"/>
  <result pre="opinion in infectious diseases20183165273430299360 51AlansariKToaimahFHAlmatarDHElTatawy LADavidsonBLQusadMIMMonoclonal antibody treatment of RSV" exact="bronchiolitis" post="in young infants: a randomized trial Pediatrics20191433e2018230830760509 52ChengZJShanJ2019 Novel"/>
  <result pre="are and what we knowInfection20201931919762 53collab: WHOClinical management of severe" exact="acute" post="respiratory infection when novel coronavirus (nCoV) infection is suspected:"/>
  <result pre="and what we knowInfection20201931919762 53collab: WHOClinical management of severe acute" exact="respiratory" post="infection when novel coronavirus (nCoV) infection is suspected: interim"/>
  <result pre="what we knowInfection20201931919762 53collab: WHOClinical management of severe acute respiratory" exact="infection" post="when novel coronavirus (nCoV) infection is suspected: interim guidance"/>
  <result pre="management of severe acute respiratory infection when novel coronavirus (nCoV)" exact="infection" post="is suspected: interim guidance 307Published January. 2020;28.https://www.who.int/docs/defaultsource/coronaviruse/clinical-management-of-novel-08cov.pdf?sfvrsn=bc7da517_2 54VetterPEckerleIKaiserLCovid-19: a"/>
  <result pre="Emergency Preparedness: Globalizing Risk, Localizing Threats Jama2018 320171743430398590 59collab: WHOCoronavirus" exact="disease" post="2019 (COVID-19) Situation Report-46Access Mar,2020Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200306-intrep-46-covid-19.pdf?sfvrsn=96b04adf_2 60ZengYZhenYChinese medical"/>
 </snippets>
</snippetsTree>
